Skip to content

Clinical trials

Terminated Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Status: Terminated Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20031
20047
20056
20062
20074
20084
20092
20107
20112
20125
20138
20144
20152
20175
20181
20192
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated76

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Dana-Farber Cancer Institute5
Fred Hutchinson Cancer Center4
Gilead Sciences4
Barbara Ann Karmanos Cancer Institute3
City of Hope Medical Center3
Case Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
Northside Hospital, Inc.2
Roswell Park Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia76
Leukemia, Lymphocytic, Chronic, B-Cell52
Lymphoma, B-Cell, Marginal Zone51
Lymphoma, Follicular49
Lymphoma, Mantle-Cell46
Lymphoma, Large B-Cell, Diffuse44
Lymphoma, Non-Hodgkin39
Burkitt Lymphoma33
Precursor Cell Lymphoblastic Leukemia-Lymphoma33
Lymphoma, Large-Cell, Immunoblastic28

Trials

Showing 76 to 76 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.